Product (Company) | Composition | Growth Factors | Processing | Storage | Shelf Life | Available Configurations | Proposed Effects and Uses |
Affinity (Organogenesis); Canton, MA, USA | Fresh amniotic membrane | NL | NL | Refrigerator | NL | Liquid |
|
Allogen (ViVex); Atlanta, GA, USA | Frozen allograft derived from amniotic fluid | TIMP-2, HGF, IL-6, TIMP-1, IL-1ra, GRO-a, TGF-B1, TGF-B2, TIMP-4 | NL | Ambient conditions, refrigerator, or frozen | 2 y at −40°C for frozen configuration and 2 y at 2–30°C in liquid configuration |
|
|
AlloWrap DS (Allosource); Centennial, CO, USA | Amniotic membrane | TGF-B1-B3, TGF-A, EGF, KGF, HGF, bFGF, IL-1, IL-2, IL-10, MMP-1–4 | NL | Ambient conditions | 2 y |
|
|
Amniofix (MiMedx Group Inc); Marietta, GA, USA | Amniotic tissue membrane composite | EGF, KGF, HA, IL-6 | PURION processa | Ambient conditions | 5 y |
|
|
Clarix Surgical Matrix (Amniox Medical Inc); Miami, FL, USA | Cryopreserved human amniotic membrane | EGF, KGF, HA, IL-6 | CRYOTEK processb | Refrigerator or freezer | 3 mo at 1–10°C; 1 y at −49 to 0°C; 2 y at −85 to −50°C |
|
|
FloGraft (Applied Biologics); Scottsdale, AZ, USA | Amnion and amniotic fluid | NL | NL | Refrigerator or freezer | NL | Liquid |
|
NuCel (Organogenesis); Canton, MA, USA | Amnion and amniotic fluid | NL | NL | NL | NL | Liquid |
|
PalinGen Flow/Sports Flow (Amnio Technology); Phoenix, AZ, USA | Amnion and amniotic fluid components | FGF, EGF, PDGF A and B, VEGF, TGFβ | NL | Freezer | NL | Liquid |
|
ReNu (Organogenesis); Canton, MA, USA | Cryopreserved amniotic suspension allograft | NL | NL | Freezer | NL | Liquid |
|
ViaShield (Globus Medical); Audubon, PA, USA | Chorion-free, dual-layer amnion patch | NL | NL | NL | NL | Sheet/membrane | NL |
Abbreviations: bFGF, basic fibroblast growth factor; EGF, epidermal growth factor; GRO, growth regulated protein alpha; HA, hyaluronic acid; HGF, hepatocyte growth factor; HGF, hepatocyte growth factor; IL, interleukin; KGF, keratinocyte growth factor; MMP, matrix matalloproteinase; NL, not listed; PDGF A and B, platelet derived growth factor alpha and beta; TGF, transforming growth factor; TIMP-2, tissue inhibitor of metalloproteinases 2; VEGF, vascular endothelial growth factor.
↵a The PURION process of cleaning, dehydration, and sterilization safely and carefully separates placental tissues, cleans and reassembles layers, and subsequently dehydrates the tissue to preserve the key elements associated with healing. The amniotic membrane scaffolding is protected while blood components are removed, so an intact extracellular matrix is left behind. No chemical cross-linking or decellularization occurs during the process.
↵b The CRYOTEK process uses cryopreservation (deep freezing) to maintain the innate biological and structural integrity of the natural tissue while maintaining its natural hydrated state.